These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18849603)
21. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States. Riad S; Goswami U; Jackson S; Hertz M; Matas A J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899 [TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. David KM; Morris JA; Steffen BJ; Chi-Burris KS; Gotz VP; Gordon RD Clin Transplant; 2005 Apr; 19(2):279-85. PubMed ID: 15740568 [TBL] [Abstract][Full Text] [Related]
23. Improved survival in heart transplant recipients in the United States: racial differences in era effect. Singh TP; Almond C; Givertz MM; Piercey G; Gauvreau K Circ Heart Fail; 2011 Mar; 4(2):153-60. PubMed ID: 21228316 [TBL] [Abstract][Full Text] [Related]
24. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Taber DJ; Gebregziabher M; Payne EH; Srinivas T; Baliga PK; Egede LE Transplantation; 2017 Feb; 101(2):402-410. PubMed ID: 26901080 [TBL] [Abstract][Full Text] [Related]
25. Effect of race on kidney transplants. Zhou YC; Cecka JM; Terasaki PI Clin Transpl; 1990; ():447-59. PubMed ID: 2103167 [TBL] [Abstract][Full Text] [Related]
26. Declining influence of race on the outcome of living-donor renal transplantation. Smith SR; Butterly DW Am J Transplant; 2002 Mar; 2(3):282-6. PubMed ID: 12096792 [TBL] [Abstract][Full Text] [Related]
27. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Soliman KM; Posadas Salas AC; Taber DJ Exp Clin Transplant; 2019 Dec; 17(6):707-713. PubMed ID: 30570456 [TBL] [Abstract][Full Text] [Related]
28. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
29. Racial differences in utilization and outcomes of hemodialysis access in the Unites States. Arhuidese IJ; AJi EA; Muhammad R; Dhaliwal J; Shukla AJ; Malas MB J Vasc Surg; 2020 May; 71(5):1664-1673. PubMed ID: 32173190 [TBL] [Abstract][Full Text] [Related]
30. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy. Zeng X; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Losanoff JE; West MS; Gruber SA Surgery; 2007 Oct; 142(4):538-44; discussion 544-5. PubMed ID: 17950346 [TBL] [Abstract][Full Text] [Related]
31. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478 [TBL] [Abstract][Full Text] [Related]
32. Blacks as donors for transplantation: suboptimal outcomes overcome by transplantation into other minorities. Callender CO; Cherikh WS; Miles PV; Hermesch A; Maddox G; Nash J; Hernandez A; Burston B Transplant Proc; 2008 May; 40(4):995-1000. PubMed ID: 18555098 [TBL] [Abstract][Full Text] [Related]
33. Impact of human leukocyte antigen-DR mismatch status on kidney graft survival in a predominantly African-American population under the newer immunosuppressive era. Karabicak I; Adekile A; Distant DA; O'Shaunessy D; Lewis S; Sumrani NB; Norin AJ; Salifu MO Transplant Proc; 2011 Jun; 43(5):1544-50. PubMed ID: 21693232 [TBL] [Abstract][Full Text] [Related]
34. Racial Disparity in Renal Transplantation: Alemtuzumab the Great Equalizer? Smith AA; John MM; Dortonne IS; Paramesh AS; Killackey M; Jaffe BM; Buell JF Ann Surg; 2015 Oct; 262(4):669-74. PubMed ID: 26366547 [TBL] [Abstract][Full Text] [Related]
35. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin. Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269 [TBL] [Abstract][Full Text] [Related]
36. The UNOS Scientific Renal Transplant Registry. Cecka JM Clin Transpl; 1996; ():1-14. PubMed ID: 9286555 [TBL] [Abstract][Full Text] [Related]
37. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. Beermann KJ; Ellis MJ; Sudan DL; Harris MT Clin Transplant; 2014 Jul; 28(7):762-7. PubMed ID: 24754564 [TBL] [Abstract][Full Text] [Related]
39. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents. Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138 [TBL] [Abstract][Full Text] [Related]
40. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study. Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]